<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="63636">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01746537</url>
  </required_header>
  <id_info>
    <org_study_id>12-612</org_study_id>
    <nct_id>NCT01746537</nct_id>
  </id_info>
  <brief_title>Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography</brief_title>
  <acronym>ATAC</acronym>
  <official_title>Automated Analysis of Anterior Chamber Inflammation by Optical Coherence Tomography</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>The Cleveland Clinic</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>The Cleveland Clinic</source>
  <oversight_info>
    <authority>United States: Food and Drug Administration</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      A prospective, observational, case series investigating the feasibility of utilizing OCT
      scans of the anterior chamber of eyes with uveitis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>June 2012</start_date>
  <completion_date type="Anticipated">June 2014</completion_date>
  <primary_completion_date type="Anticipated">June 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Cohort, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>Use the OCT to objectively image and grade the degree of anterior chamber inflammation in eyes with inactive and active uveitis.</measure>
    <time_frame>one year</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">250</enrollment>
  <condition>Uveitis</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with inactive and active uveitis.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  All patients presenting to Cole Eye Institute with uveitis.

        Exclusion Criteria:

          -  Inability to provide informed consent, including non-English speaking and
             cognitively/mentally impaired.

          -  Severe corneal opacities preventing imaging of anterior chamber
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Sunil K Srivastava, M.D.</last_name>
    <phone>216-636-2286</phone>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Kimberly M Baynes, study coordinator</last_name>
    <phone>216-44-2566</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Cole Eye Institute</name>
      <address>
        <city>Cleveland</city>
        <state>Ohio</state>
        <zip>44195</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sunil K Srivastava, M.D.</last_name>
      <phone>216-636-2286</phone>
    </contact>
    <contact_backup>
      <last_name>Kimberly M Baynes, study coordinator</last_name>
      <phone>216-444-2566</phone>
    </contact_backup>
    <investigator>
      <last_name>Sunil K Srivastava, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>December 2012</verification_date>
  <lastchanged_date>December 10, 2012</lastchanged_date>
  <firstreceived_date>December 7, 2012</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>The Cleveland Clinic</investigator_affiliation>
    <investigator_full_name>Sunil Srivastava</investigator_full_name>
    <investigator_title>Medical Doctor</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
    <mesh_term>Uveitis</mesh_term>
    <mesh_term>Chorioretinitis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
